Selective expression of mRNA coding for the truncated form of erythropoietin receptor in hematopoietic cells and its decrease in patients with polycythemia vera

Blood

Volumn 90, Issue 1, 1997, Pages 97-104

  Chiba, Shigeru ^b   Takahashi, Tokiharu ^b   Takeshita, Kenichi ^b   Minowada, Jun ^b   Yazaki, Yoshio ^b   Ruddle, Frank H ^b   Hirai, Hisamaru ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN RECEPTOR; MESSENGER RNA;

ARTICLE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; GENE EXPRESSION REGULATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; POLYCYTHEMIA VERA; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RECEPTOR DENSITY; RNA SPLICING; TRANSCRIPTION REGULATION;

EID: 0031010122     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.1.97     Document Type: Article

References (36)

1. Krantz SB: Erythropoietin. Blood 77:419, 1991
2. Lodish HF, Hilton D, Longmore G, Watowich SS, Yoshimura A: The erythropoietin receptor: Dimerization, activation, and tumori-genesis. Cold Spring Harb Symp Quant Biol 57:95, 1992
3. Witthuhn BA, Quelle FW, Silvennoinen O, Yi T, Tang B, Miura O, Ihle JN: JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 74:227, 1993
4. Maouche L, Tournamille C, Hattab C, Boffa G, Cartron JP, Chretien S: Cloning of the gene encoding the human erythropoietin receptor. Blood 78:2557, 1991
5. Noguchi CT, Bae KS, Chin K, Wada Y, Schechter AN, Hankins WD: Cloning of the human erythropoietin receptor gene. Blood 78:2548, 1991
6. Nakamura Y, Komatsu N, Nakauchi H: A truncated erythropoietin receptor that fails to prevent programmed cell death of erythroid cells. Science 257:1138, 1992
7. Nakamura Y, Nakauchi H: A truncated erythropoietin receptor and cell death: A reanalysis. Science 264:588, 1994
8. Tefferi A, Silverstein MN: Diagnosis and treatment of polycythemia vera, agnogenic myeloid metaplasia and essential thrombocythemia, in Wiernik PH, Canellos GP, Dutcher JP, Kyle RA (eds): Neoplastic Diseases of the Blood (ed 3). New York, NY, Churchill Livingstone, 1996, p 137
9. Mitani K, Ogawa S, Tanaka T, Miyoshi H, Kurokawa M, Mano H, Yazaki Y, Ohki M, Hirai H: Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26:q22) causes blastic crisis in chronic myelocytic leukemia. EMBO J 13:504, 1994
10. Minowada J: Leukemia cell lines. Cancer Rev 10:1, 1988
11. Ogura M, Morishima Y, Ohno R, Kato Y, Hirabayashi N, Nagura H, Saito H: Establishment of a novel human megakaryoblastic leukemia cell line, MEG-01, with positive Philadelphia chromosome. Blood 66:1384, 1985
12. Kitamura T, Tange T, Terasawa T, Chiba S, Kuwaki T, Miyagawa K, Piao YF, Miyazono K, Urabe A, Takaku F: Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. J Cell Physiol 140:323, 1989
13. Chiba S, Takaku F, Tange T, Shibuya K, Misawa C, Sasaki K, Miyagawa K, Yazaki Y, Hirai H: Establishment and erythroid differentiation of a cytokine-dependent human leukemic cell line F-36: A parental line requiring granulocyte-macrophage colony-stimulating factor or interleukin-3, and a subline requiring erythropoietin. Blood 78:2261, 1991
14. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
15. Youssoutian H, Longmore G, Neumann D, Yoshimura A, Lodish HF: Structure, function, and activation of the erythropoietin receptor. Blood 81:2223, 1993
16. Mayeux P, Lacombe C, Casadevall N, Chretien S, Dusanter I, Gisselbrecht S: Structure of the murine erythropoietin receptor complex. Characterization of the erythropoietin cross-linked proteins. J Biol Chem 266:23380, 1991
17. Damen J, Mui AL, Hughes P, Humphries K, Krystal G: Erythropoietin-induced tyrosine phosphorylations in a high erythropoietin receptor-expressing lymphoid cell line. Blood 80:1923, 1992
18. 125I-Epo cross-linking in cells expressing wild-type or mutant receptors. Blood 81:1739, 1993
19. Takahashi T, Chiba S, Hirano N, Yazaki Y, Hirai H: Characterization of three erythropoietin (Epo)-binding proteins in various human Epo-responsive cell lines and in cells transfected with human Epo-receptor cDNA. Blood 85:106, 1995
20. Nakamura Y, Tokumoto Y, Nakauchi H: Role of a truncated erythropoietin receptor for erythroid differentiation. Biochem Biophys Res Commun 218:205, 1996
21. Wu H, Liu X, Jaenisch R, Lodish HF: Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 83:59, 1995
22. Lin CS, Lim SK, D'Agati V, Costantini F: Differential effects of an erythropoietin receptor gene disruption on primitive and definitive erythropoiesis. Genes Dev 10:154, 1996
23. Athens JW: Polycythemia vera, in Lee GR, Bithell TC, Foerster J, Athens JW, Lukens NJ (eds): Wintrobe's Clinical Hematology, vol 2. Philadelphia, PA, Lea & Febiger, 1993, p 1999
24. Golde DW, Cline MJ: Erythropoietin responsiveness in polycythaemia vera. Br J Haematol 29:567, 1975
25. Prchal JF, Adamson JW, Murphy S, Steinmann L, Fialkow PJ: Polycythemia vera. The in vitro response of normal and abnormal stem cell lines to erythropoietin. J Clin Invest 61:1044, 1978
26. de la Chapelle A, Traskelin AL, Juvonen E: Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosis. Proc Natl Acad Sci USA 90:4495, 1993
27. Sokol L, Luhovy M, Guan Y, Prchal JF, Semenza GL, Prchal JT: Primary familial polycythemia: A frameshift mutation in the erythropoietin receptor gene and increased sensitivity of erythroid progenitors to erythropoietin. Blood 86:15, 1995
28. Hess G, Rose P, Gamm H, Papadileris S, Huber C, Seliger B: Molecular analysis of the erythropoietin receptor system in patients with polycythaemia vera. Br J Haematol 88:794, 1994
29. Le Couedic J-P, Mitjavila M-T, Villeval J-L, Feger F, Gobert S, Mayeux P, Casadevall N, Vainchenker W: Missense mutation of the erythropoietin receptor is a rare event in human erythroid malignancies. Blood 87:1502, 1996
30. Ash RC, Detrick RA, Zanjani ED: In vitro studies of human pluripotential hematopoietic progenitors in polycythemia vera. Direct evidence of stem cell involvement. J Clin Invest 69:1112, 1982
31. Longmore GD, Pharr P, Neumann D, Lodish HF: Both megakaryocytopoiesis and erythropoiesis are induced in mice infected with a retrovirus expressing an oncogenic erythropoietin receptor. Blood 82:2386, 1993
32. Orlic D, Anderson S, Biesecker LG, Sorrentino BP, Bodine DM: Pluripotent hematopoietic stem cells contain high levels of mRNA for c-kit, GATA-2, p45 NF-E2, and c-myb and low levels or no mRNA for c-fms and the receptors for granulocyte colony-stimulating factor and interleukins 5 and 7. Proc Natl Acad Sci USA 92:4601, 1995
33. Pharr PN, Hankins D, Hofbauer A, Lodish HF, Longmore GD: Expression of a constitutively active erythropoietin receptor in primary hematopoietic progenitors abrogates erythropoietin dependence and enhances erythroid colony-forming unit, erythroid burst-forming unit, and granulocyte/macrophage progenitor growth. Proc Natl Acad Sci USA 90:938, 1993
34. Singh AB, Singh M, Palekar S, Levy S, Nunn C, Mann RA: The effects of recombinant human erythropoietin on the cell mediated immune response of renal failure patients. J Med 23:289, 1992
35. Lee SK, Park MS, Han DC, Hwang SD, Moon C, Lee HB: Effects of erythropoietin-induced hemopoiesis on peritoneal transport and on in vitro T cell response in CAPD. Adv Perit Dial 8:453, 1992
36. Ueki Y, Nagata M, Miyake S, Tominaga Y: Lymphocyte subsets in hemodialysis patients treated with recombinant human erythropoietin. J Clin Immunol 13:279, 1993